Cytta Corp to Report Marketable Securities in Excess of $6,000,000 in Delayed March 31, 2025, 10-Q

Rhea-AI Summary

Cytta Corp (OTC:CYCA) announced updates regarding its delayed March 31, 2025, 10-Q filing and OTCQB status. The company will report marketable securities worth over $6 million on its balance sheet, consisting of 2,44,513 Class A Reticulate Micro shares.

The company's temporary move from OTCQB to Expert Market is solely due to the delayed 10-Q filing. Cytta is working with new auditors to complete the quarterly review, after which it expects to regain OTCQB status as it meets all other eligibility requirements.

Positive

• Company holds marketable securities valued at over $6 million
• Expected to regain OTCQB status upon 10-Q filing completion
• Meets all other OTCQB eligibility requirements

Negative

• Delayed filing of March 31, 2025 10-Q report
• Temporary downgrade from OTCQB to Expert Market status

Upon Completion of the 10-Q Quarterly Interim Review filing, Cytta Corp will be Current and Will Regain OTCQB Status

LAS VEGAS, NEVADA / ACCESS Newswire / July 21, 2025 / Cytta Corp.(OTCExpertMarket:CYCA), wishes to report that the delay in filing the March 31, 2025, 10-Q is the sole reason the Company has been moved from OTCQB to Expert. The new Auditors have also agreed that the Company will now be able to report the 2,44,513 Class A Reticulate Micro shares that Cytta Corp. holds as Marketable Securities with a value in excess of six million dollars ($6,000,000+) on the March 31, 2025, 10-Q Balance Sheet.

The Company is diligently working with its new Auditors to complete the delayed March 31, 2025, 10-Q Quarterly Interim Review. Upon completion of the 10Q Quarterly Interim Review filing, the Company will be current and will regain its OTCQB status, as the Company meets all the eligibility requirements of the OTCQB Rules.

About Cytta Corp

Cytta Corp is a pioneering technology company specializing in developing and commercializing cutting-edge safety and security solutions, including CyttaCOMMS and CyttaCARES. Cytta's proprietary innovations redefine real-time intelligence, data security, and mission-critical communications for industries spanning defense, public safety, critical infrastructure, and enterprise operations.

Through Cytta Labs, their venture incubator, Cytta incubates, accelerates, combines, and spins out breakthrough technologies, transforming them into high-growth ventures. By seamlessly integrating proprietary product development, venture acceleration, and structured liquidity event exit strategies, Cytta Corp is revolutionizing the future of safety, security, and intelligence on a global scale. Learn more at www.cytta.com.

For Cytta Corp:

Cytta Corp
Toll-Free: 1-877-CYTTAUS (298-8287)
Local: 1-740-CYTTAUS (298-8287)
Website: www.cytta.com
Email: info@cytta.com

SOURCE: Cytta Corp.

View the original press release on ACCESS Newswire

FAQ

What caused Cytta Corp (CYCA) to move from OTCQB to Expert Market?

Cytta Corp was moved from OTCQB to Expert Market solely due to the delay in filing its March 31, 2025 10-Q report.

How much are Cytta Corp's (CYCA) marketable securities worth in the March 2025 10-Q?

Cytta Corp will report marketable securities valued at over $6 million, consisting of 2,44,513 Class A Reticulate Micro shares.

Will Cytta Corp (CYCA) regain its OTCQB status?

Yes, Cytta Corp will regain OTCQB status upon completion of the delayed March 31, 2025 10-Q filing, as it meets all other OTCQB eligibility requirements.

What is Cytta Corp (CYCA) doing to address the delayed 10-Q filing?

Cytta Corp is working diligently with its new auditors to complete the delayed March 31, 2025 10-Q Quarterly Interim Review.